Assets Alterar Data
Acadia Pharmaceuticals USD 632.54M 10.23M 2023-09
Acorda Therapeutics USD 364.7M 10.21M 2023-06
Agios Pharmaceuticals USD 1.01B 77.9M 2023-09
Alnylam Pharmaceuticals USD 3.84B 436.68M 2023-09
Arrowhead Research USD 765.55M 30.3M 2023-09
AstraZeneca USD 96.09B 457M 2023-09
Bluebird Bio USD 613.61M 49.78M 2023-09
Bristol-Myers Squibb USD 91.26B 2.23B 2023-09
Eli Lilly USD 57.92B 3.1B 2023-09
Enanta Pharmaceuticals USD 462.28M 32.89M 2023-09
Esperion Therapeutics USD 221.3M 13.32M 2023-09
Halozyme Therapeutics USD 1.89B 82.22M 2023-09
Heron Therapeutics USD 229.2M 27.98M 2023-09
Insmed USD 1.32B 114.27M 2023-09
Lexicon Pharmaceuticals USD 276.48M 40.24M 2023-09
Ligand Pharmaceuticals USD 769.21M 11.1M 2023-09
Minerva Neurosciences USD 63.13M 4.01M 2023-09
Moderna USD 19.45B 2.43B 2023-09
PTC Therapeutics USD 1.26B 78.24M 2023-09
Takeda JPY 14.87T 79.15B 2023-09
Teva Pharmaceutical Industries USD 42.09B 1.01B 2023-09
Ultragenyx Pharmaceutical USD 1.24B 73.17M 2023-09
Vanda Pharmaceuticals USD 641.68M 2.85M 2023-06
Veracyte USD 1.12B 36.17M 2023-09



Vanda Pharmaceuticals Ativos - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Mar 2024.